17 | VaccinesIBA
10/2021
-
09/2004 |
11 | RNA (Ribonucleic Acid)IBA
01/2021
-
10/2002 |
9 | Proteins (Proteins, Gene)FDA Link
10/2021
-
05/2005 |
7 | CytokinesIBA
01/2022
-
11/2009 |
6 | AntibodiesIBA
10/2021
-
05/2005 |
5 | Glycoproteins (Glycoprotein)IBA
01/2012
-
02/2006 |
4 | Smallpox Vaccine (Vaccine, Smallpox)FDA Link
10/2021
-
03/2007 |
4 | Interleukin-2 (IL2)IBA
01/2021
-
03/2009 |
3 | Antiviral Agents (Antivirals)IBA
01/2022
-
11/2015 |
3 | ChemokinesIBA
01/2021
-
11/2009 |
3 | ImmunosorbentsIBA
01/2016
-
03/2004 |
3 | EnzymesIBA
01/2016
-
03/2004 |
2 | 5' Untranslated Regions (5' UTR)IBA
01/2021
-
11/2016 |
2 | Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2017
-
01/2017 |
2 | src-Family KinasesIBA
11/2017
-
01/2017 |
2 | Amino AcidsFDA Link
12/2010
-
07/2008 |
2 | Peptides (Polypeptides)IBA
12/2010
-
07/2008 |
2 | Chemokine CCL5IBA
11/2009
-
06/2004 |
2 | Pharmaceutical PreparationsIBA
09/2008
-
07/2002 |
1 | Particulate MatterIBA
01/2022 |
1 | ProteomeIBA
12/2021 |
1 | Cocaine (Cocaine HCl)IBA
12/2021 |
1 | AntigensIBA
10/2021 |
1 | Attenuated VaccinesIBA
01/2021 |
1 | 1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
01/2021 |
1 | Interleukin-17 (Interleukin 17)IBA
01/2021 |
1 | Neuraminidase (Sialidase)IBA
10/2020 |
1 | Anti-Infective Agents (Microbicides)IBA
01/2020 |
1 | ORALIT (ORS)IBA
01/2020 |
1 | Influenza Vaccines (Influenza Vaccine)FDA Link
01/2020 |
1 | 2-(2,4-dimethylphenyl)indan-1,3-dioneIBA
01/2020 |
1 | smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
01/2020 |
1 | Biomarkers (Surrogate Marker)IBA
01/2020 |
1 | T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 |
1 | AcidsIBA
01/2020 |
1 | Matrix Metalloproteinases (MMPs)IBA
01/2019 |
1 | Nucleic AcidsIBA
01/2019 |
1 | AIDS VaccinesIBA
01/2018 |
1 | salicylhydroxamic acid (SHAM)IBA
01/2018 |
1 | OvalbuminIBA
11/2017 |
1 | Fc Receptors (Fc Receptor)IBA
01/2017 |
1 | AerosolsIBA
01/2017 |
1 | Biological ProductsIBA
01/2017 |
1 | Toll-Like Receptors (Toll-Like Receptor)IBA
01/2017 |
1 | Poly UIBA
11/2016 |
1 | 3' Untranslated Regions (3' UTR)IBA
11/2016 |
1 | Viral VaccinesIBA
01/2016 |
1 | Viral RNAIBA
07/2015 |
1 | Papillomavirus Vaccines (HPV Vaccines)IBA
12/2014 |
1 | MF59 oil emulsionIBA
10/2014 |
1 | Interleukin-10 ReceptorsIBA
01/2014 |
1 | Interleukin-10 (Interleukin 10)IBA
05/2013 |
1 | Subunit VaccinesIBA
01/2012 |
1 | HLA Antigens (Human Leukocyte Antigens)IBA
12/2010 |